These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2171602)
41. The importance of dose and dose intensity in lung cancer chemotherapy. Murray N Semin Oncol; 1987 Dec; 14(4 Suppl 4):20-8. PubMed ID: 2825357 [TBL] [Abstract][Full Text] [Related]
42. Cisplatin and etoposide alternating with vincristine, doxorubicin and cyclophosphamide in patients with small cell lung cancer. Littlewood TJ; Smith AP; Anderson G; Chappell AG; James KW Eur J Respir Dis; 1985 Oct; 67(4):294-300. PubMed ID: 3000808 [TBL] [Abstract][Full Text] [Related]
43. Rationale for clinical application of hyperthermia and drugs. Engelhardt R Strahlenther Onkol; 1987 Jul; 163(7):428-9. PubMed ID: 3039673 [No Abstract] [Full Text] [Related]
44. [Pilot study of sequential chemotherapy and radiation therapy using of liniac and fast neutron for limited small cell lung cancer]. Takiguchi Y; Nagao K; Miyamoto T; Takamura M; Yasukawa T; Kuriyama T Gan To Kagaku Ryoho; 1995 Jun; 22(7):957-9. PubMed ID: 7794004 [No Abstract] [Full Text] [Related]
45. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028 [TBL] [Abstract][Full Text] [Related]
46. Dose-intensive chemotherapy in extensive-stage small cell lung cancer. Fukuoka M; Masuda N; Takada M; Kodama N; Kawahara M; Furuse K Semin Oncol; 1994 Feb; 21(1 Suppl 1):43-7. PubMed ID: 7512276 [No Abstract] [Full Text] [Related]
47. Addition of etoposide to cyclophosphamide, doxorubicin, and vincristine for remission induction and survival in patients with small cell lung cancer. Messeih AA; Schweitzer JM; Lipton A; Harvey HA; Simmonds MA; Stryker JA; Ricci JA; Hoffman SL; Gottleib RJ; Dixon RH Cancer Treat Rep; 1987 Jan; 71(1):61-6. PubMed ID: 3024828 [TBL] [Abstract][Full Text] [Related]
48. Etoposide compared with the combination of vincristine, doxorubicin, and cyclophosphamide in the treatment of small cell lung cancer. McIllmurray MB; Bibby RJ; Taylor BE; Ormerod LP; Edge JR; Wolstenholme RJ; Willey RF; O'Reilly JF; Horsfield N; Johnson CE Thorax; 1989 Mar; 44(3):215-9. PubMed ID: 2539655 [TBL] [Abstract][Full Text] [Related]
49. Surgery for cure of small cell bronchial carcinoma (SCLC) at early stages and postoperative combined modality treatment. Karrer K; Denck H; Karnicka-Mlodkowska H; Drings P; Erzen J; Salzer GM; J Chemother; 1989 Jul; 1(4 Suppl):1207-8. PubMed ID: 16312836 [No Abstract] [Full Text] [Related]
50. Thoracic radiation therapy in limited stage small-cell lung cancer: timing is everything...isn't it? Perry MC J Clin Oncol; 2006 Aug; 24(24):3815-6. PubMed ID: 16921030 [No Abstract] [Full Text] [Related]
51. Combined modality therapy for small cell lung cancer. Saijo N Oncology; 1992; 49 Suppl 1():2-9; discussion 10. PubMed ID: 1323808 [TBL] [Abstract][Full Text] [Related]
52. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update. Ettinger DS Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538 [TBL] [Abstract][Full Text] [Related]
53. [Results of a sequential polychemotherapy (adriamycin, vincristine, cyclophosphamide, methotrexate) in small-cell and undifferentiated bronchial cancer]. Taytard A; Chomy P; Courty G; Gachie JP; Roquain J Rev Fr Mal Respir; 1980; 8(3):225-32. PubMed ID: 6314444 [TBL] [Abstract][Full Text] [Related]
54. Chemotherapy-induced remission in a patient with small cell carcinoma of the lung and hairy cell leukemia. Kuebler JP; Earhart R; Hafez GR Cancer; 1985 Jun; 55(12):2758-60. PubMed ID: 2986824 [TBL] [Abstract][Full Text] [Related]
55. Dose-intensive weekly alternating chemotherapy for patients with small cell lung cancer: randomized trial, can it improve survival of patients with good prognostic factors? Masutani M; Ochi Y; Kadota A; Akusawa H; Kisohara A; Takahashi N; Koya Y; Horie T Oncol Rep; 2000; 7(2):305-10. PubMed ID: 10671676 [TBL] [Abstract][Full Text] [Related]
56. Lactic acidosis with small cell carcinoma. Rapid response to chemotherapy. Rice K; Schwartz SH Am J Med; 1985 Oct; 79(4):501-3. PubMed ID: 2996348 [TBL] [Abstract][Full Text] [Related]
57. Cyclic alternating chemotherapy for small cell carcinoma of the lung. Murray N; Shah A; Wilson K; Goldie J; Voss N; Fryer C; Klimo P; Coy P; Hadzic E; Gudauskas G Cancer Treat Rep; 1985 Nov; 69(11):1241-2. PubMed ID: 3004724 [TBL] [Abstract][Full Text] [Related]
58. Alternating chemotherapy with cyclophosphamide/adriamycin/vincristine (CAV) and cisplatin/etoposide (PVP) against small cell lung cancer. Eastern Shikoku Lung Cancer Chemotherapy Group. Bando H; Takishita Y; Ogura T; Sone S; Shimizu E; Nakayama T; Doi H; Kobayashi M Jpn J Clin Oncol; 1991 Dec; 21(6):435-9. PubMed ID: 1666660 [TBL] [Abstract][Full Text] [Related]
59. [Treatment of microcytic carcinoma of the lung with vincristine, adriamycin, cyclophosphamide and VP-16]. Sangro Gómez-Acebo B; Díaz-Rubio García E; Martín Jiménez M; González Larriba JL; Vila Borrajo C Rev Clin Esp; 1986 Oct; 179(6):296-301. PubMed ID: 3025943 [No Abstract] [Full Text] [Related]
60. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer. Shepherd FA; Evans WK; MacCormick R; Feld R; Yau JC Cancer Treat Rep; 1987 Oct; 71(10):941-4. PubMed ID: 2820571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]